
GC73497
PHI-101
Also known as 3-(carbamoylamino)-5-[2-(3-fluorophenyl)ethynyl]-N-[(3S)-piperidin-3-yl]thiophene-2-carboxamide
PHI-101 is an orally active FLT3 inhibitor that overcomes resistance to multiple drug-resistant mutations
ChemicalCAS2127107-15-5MW386.44FormulaC19H19FN4O2S
- CAS number
- 2127107-15-5
- Molecular weight
- 386.44
- Formula
- C19H19FN4O2S
- Solubility
- DMSO : 100 mg/mL (258·77 mM; Need ultrasonic)
- InChIKey
- ULVAGWVTXBTFRN-AWEZNQCLSA-N
- Catalogue number
- GC73497
- Brand
- GLPBIO
Computed properties PubChem CID 130358571 · XLogP 2.6 · TPSA 124 Ų · H-bond donors 4
- XLogP
- 2.6
- TPSA
- 124 Ų
- H-bond donors
- 4
- H-bond acceptors
- 5
- Rotatable bonds
- 5
- Heavy atoms
- 27
SMILES C1C[C@@H](CNC1)NC(=O)C2=C(C=C(S2)C#CC3=CC(=CC=C3)F)NC(=O)N
Computed descriptors from PubChem (CID 130358571), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il